These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2157776)

  • 21. Residual erythroid progenitors in W/W mice respond to erythropoietin in the absence of steel factor signals.
    Pharr PN; Hofbauer A; Worthington RE; Longmore GD
    Int J Hematol; 2000 Aug; 72(2):178-85. PubMed ID: 11039666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of erythropoietin to CFU-E derived from fetal mouse liver cells.
    Fukamachi H; Saito T; Tojo A; Kitamura T; Urabe A; Takaku F
    Exp Hematol; 1987 Sep; 15(8):833-7. PubMed ID: 3305053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Onset of erythropoietin response in murine erythroid colony-forming units: assignment to early S-phase in a specific cell generation.
    Landschulz KT; Boyer SH; Noyes AN; Rogers OC; Frelin LP
    Blood; 1992 May; 79(10):2749-58. PubMed ID: 1316785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Responsiveness to recombinant human erythropoietin (rh-Epo) of marrow erythroid progenitors (CFU-E and BFU-E) from B-chronic lymphocytic leukemia (B-CLL).
    Tsatalas C; Chalkia P; Tsantali C; Kakoulidis I; Garyfallos A; Klonizakis I; Panayiotopoulos S
    J Exp Clin Cancer Res; 1997 Jun; 16(2):163-70. PubMed ID: 9261742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perturbation of autocrine/paracrine loops of burst-forming units of erythroid-derived cells in rHuEPO-hyporesponsive hemodialysis patients.
    Nakao K; Wada J; Ota K; Ichikawa H; Akagi S; Okamoto A; Hida K; Nagake Y; Makino H
    Am J Kidney Dis; 2003 Mar; 41(3):624-36. PubMed ID: 12612986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating CFU-E during hematopoietic recovery after allogeneic bone marrow transplantation: relationship to erythroid engraftment.
    Vannucchi AM; Bosi A; Lombardini L; Grossi A; Bacci P; Guidi S; Saccardi R; Rossi-Ferrini P
    Exp Hematol; 1995 Dec; 23(13):1337-40. PubMed ID: 7498360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and characterization of erythropoietin receptors on normal human bone marrow cells.
    Hoshino S; Teramura M; Takahashi M; Motoji T; Oshimi K; Ueda M; Mizoguchi H
    Int J Cell Cloning; 1989 May; 7(3):156-67. PubMed ID: 2543713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the receptor for erythropoietin by cross-linking to Friend virus-infected erythroid cells.
    Sawyer ST; Krantz SB; Luna J
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3690-4. PubMed ID: 3035548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anemia of chronic inflammatory arthritides: treatment with recombinant human erythropoietin.
    Birgegård G; Gudbjrönsson B; Hällgren R; Wide L
    Contrib Nephrol; 1991; 88():295-303; discussion 304-5. PubMed ID: 2040192
    [No Abstract]   [Full Text] [Related]  

  • 31. Erythropoietin receptors in polycythemia vera.
    Means RT; Krantz SB; Sawyer ST; Gilbert HS
    J Clin Invest; 1989 Oct; 84(4):1340-4. PubMed ID: 2551927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin receptors on murine erythroid colony-forming units: natural history.
    Landschulz KT; Noyes AN; Rogers O; Boyer SH
    Blood; 1989 May; 73(6):1476-86. PubMed ID: 2540854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological characterization of recombinant human erythropoietin.
    Krumwieh D; Arnold I; Seiler FR
    Behring Inst Mitt; 1988 Aug; (83):193-201. PubMed ID: 3240225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
    Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
    J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Erythropoietin substitution in anemic patients with rheumatoid arthritis?].
    Bommer J
    Dtsch Med Wochenschr; 1991 Sep; 116(37):1412. PubMed ID: 1889357
    [No Abstract]   [Full Text] [Related]  

  • 36. Improvement of erythroid toxicity by lentinan and erythropoietin in mice treated with chemotherapeutic agents.
    Takatsuki F; Miyasaka Y; Kikuchi T; Suzuki M; Hamuro J
    Exp Hematol; 1996 Feb; 24(3):416-22. PubMed ID: 8599970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant EPO therapy increases erythrocyte expression of complement regulatory proteins.
    Ohi H; Tamano M; Sudo S; Okada N
    Am J Kidney Dis; 2003 Jan; 41(1):179-85. PubMed ID: 12500235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia.
    Bessho M; Jinnai I; Matsuda A; Saito M; Hirashima K
    Int J Cell Cloning; 1990 Nov; 8(6):445-58. PubMed ID: 2273298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the erythropoietin receptors of erythroleukemic cells.
    Wang FF; Wang YJ; Lee HJ; Fong JC
    Biochem Int; 1989 Jan; 18(1):163-71. PubMed ID: 2541719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand binding kinetics of a soluble full-length murine erythropoietin receptor.
    Avedissian LS; Poola I; Spivak JL
    Biochem Biophys Res Commun; 1995 Nov; 216(1):62-8. PubMed ID: 7488125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.